Investigation of use in 5-FU release: Synthesis of temperature and pH responsive P(NVCL-co-VIm)/PVP hydrogels

被引:0
作者
Ahmet Güngör
Tonguç Özdemir
Rükan Genç
机构
[1] Sabancı University,Faculty of Engineering and Natural Sciences
[2] Mersin University,Department of Chemical Engineering, Faculty of Engineering
来源
Polymer Bulletin | 2024年 / 81卷
关键词
Dual responsive polymer; Poly(N-vinylcaprolactam); 1-Vinylimidazole; Drug release; 5-Fluorouracil; Polyvinylpyrrolidone;
D O I
暂无
中图分类号
学科分类号
摘要
5-fluorouracil (5-FU) forms the basis of many chemotherapy regimens and is one of the most common preferred chemotherapeutic drugs. In this study, the synthesis of temperature and pH responsive hydrogels in the release of 5-fluorouracil (5-FU) was studied to prevent drug release during blood circulation and uncontrolled overdose drug concentration at the tumor site. In this regard, the synthesis of temperature sensitive polymer Poly(N-vinylcaprolactam) PNVCL, temperature and pH sensitive polymers P(NVCL-co-VIm) and P(NVCL-co-VIm)/PVP hydrogels was carried out by the free radical polymerization method. DSC analysis revealed that as a result of copolymerization of PNVCL with hydrophilic 1-vinylimidazole (VIm) and polyvinylpyrrolidone (PVP), the lower critical solution temperature (LCST) increased and was close to the human body temperature. In addition, it was concluded from pH sensitivity analysis that the swelling ratios of the hydrogels changed with the medium pH. Additionally, hydrogels swelled in the acidic medium but shrunk in the alkaline medium. Accordingly, 5-FU release was investigated in different temperatures (25 °C and 37 °C) and pH (pH 5.5 and 7.4) medium and approximately 96% drug release was reached at 37 °C and pH 7.4. Consequently, P(NVCL-co-VIm)/PVP hydrogels at different pH and temperature mediums could be beneficially utilized as a material with the potential to be used in targeted drug delivery systems.
引用
收藏
页码:2091 / 2109
页数:18
相关论文
共 148 条
[1]  
Hanahan D(2000)The Hallmarks of cancer review evolve progressively from normalcy via a series of pre Cell 100 57-70
[2]  
Weinberg RA(2016)Current challenges in cancer treatment Clin Ther 38 1551-1566
[3]  
Zugazagoitia J(2005)Chemotherapy and the war on cancer Nat Rev Cancer 5 65-72
[4]  
Guedes C(1979)Basic mechanisms of chemotherapy Chest 76 771-780
[5]  
Ponce S(2022)Extracellular vesicles as an emerging drug delivery system for cancer treatment: current strategies and recent advances Biomed Pharmacother 153 113480-422
[6]  
Chabner BA(2012)Oral complications of cancer and cancer therapy CA Cancer J Clin 62 400-20
[7]  
Roberts TG(2015)Targeted cancer therapy: the next generation of cancer treatment Curr Drug Discov Technol 12 3-432
[8]  
Mitchison DA(2008)From single-to multi-target drugs in cancer therapy: when aspecificity becomes an advantage Curr Med Chem 15 422-374
[9]  
Wang Z(2005)Targeted drug delivery in cancer therapy Technol Cancer Res Treat 4 363-608
[10]  
Mo H(2021)Stimuli-responsive polymeric nanoplatforms for cancer therapy Front Bioeng Biotechnol 9 528-1222